Imagion Biosystems Ltd (IBX)

Currency in AUD
0.00500
0.00000(0.00%)
Delayed Data·
Trading near 52-week Low
IBX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.005000.00500
52 wk Range
0.005000.03500
Key Statistics
Bid/Ask
0.005 / 0.006
Prev. Close
0.005
Open
0.005
Day's Range
0.005-0.005
52 wk Range
0.005-0.035
Volume
100K
Average Volume (3m)
2.18M
1-Year Change
-78.2609%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IBX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Imagion Biosystems Ltd News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
Aug 24, 2026
EPS / Forecast
-- / --
Revenue / Forecast
525.93K / --
EPS Revisions
Last 90 days

IBX Income Statement

Compare IBX to Peers and Sector

Metrics to compare
IBX
Peers
Sector
Relationship
P/E Ratio
−0.6x−4.9x−0.2x
PEG Ratio
−0.02−0.090.00
Price/Book
−0.8x3.1x2.6x
Price / LTM Sales
4.7x2.0x2.8x
Upside (Analyst Target)
-129.0%63.4%
Fair Value Upside
Unlock11.7%9.5%Unlock

Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.33M0.99%26.67K
Other Institutional Investors
79.49M14.72%397.43K
Public Companies & Retail Investors
455.12M84.29%2.28M
Total
539.94M100.00%2.7M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Celtic Capital Pte Ltd2.23%12,054,48260
Irh Pty Ltd2.23%12,020,32960

FAQ

What Is the Imagion Biosystems (IBX) Stock Price Today?

The Imagion Biosystems stock price today is 0.00500 AUD.

What Stock Exchange Does Imagion Biosystems Trade On?

Imagion Biosystems is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Imagion Biosystems?

The stock symbol for Imagion Biosystems is "IBX."

What Is the Imagion Biosystems Market Cap?

As of today, Imagion Biosystems market cap is 2.70000M AUD.

What Is Imagion Biosystems's Earnings Per Share (TTM)?

The Imagion Biosystems EPS (TTM) is -0.011.

From a Technical Analysis Perspective, Is IBX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Imagion Biosystems Stock Split?

Imagion Biosystems has split 2 times.

What is the current trading status of Imagion Biosystems (IBX)?

As of Nov 13, 2026, Imagion Biosystems (IBX) is trading at a price of 0.00500 AUD, with a previous close of 0.00500 AUD. The stock has fluctuated within a day range of 0.00500 AUD to 0.00500 AUD, while its 52-week range spans from 0.00500 AUD to 0.03500 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.